Cargando…

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

OBJECTIVE: The inflammatory cytokine interleukin-6 (IL-6) is associated with cardiovascular (CV) and kidney outcomes in various populations. However, data in patients with type 2 diabetes are limited. We assessed the association of IL-6 with CV and kidney outcomes in the Canagliflozin Cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koshino, Akihiko, Schechter, Meir, Sen, Taha, Vart, Priya, Neuen, Brendon L., Neal, Bruce, Arnott, Clare, Perkovic, Vlado, Ridker, Paul M., Tuttle, Katherine R., Hansen, Michael K., Heerspink, Hiddo J.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2022
Materias:	Pathophysiology/Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862371/ https://www.ncbi.nlm.nih.gov/pubmed/36134918 http://dx.doi.org/10.2337/dc22-0866

Ejemplares similares

Association Between Circulating GDF‐15 and Cardio‐Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial
por: Sen, Taha, et al.
Publicado: (2021)

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
por: Sen, Taha, et al.
Publicado: (2021)

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA(1c), disease duration and treatment intensity: results from the CANVAS Program
por: Young, Tamara K., et al.
Publicado: (2021)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Mechanisms of action of the sodium‐glucose cotransporter‐2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial
por: Sen, Taha, et al.
Publicado: (2022)

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials
por: Fletcher, Robert A., et al.
Publicado: (2023)

Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
por: Yu, Jie, et al.
Publicado: (2021)

Acute Modulation of Toll-Like Receptors by Insulin
por: Ghanim, Husam, et al.
Publicado: (2008)

A role of the adaptive immune system in glucose homeostasis
por: Bronsart, Laura L, et al.
Publicado: (2016)

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
por: Kilpatrick, Eric S., et al.
Publicado: (2008)

Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes
por: Baker, Nathaniel L., et al.
Publicado: (2018)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Presentation, pathology and prognosis of renal disease in type 2 diabetes
por: Tan, Jasmine, et al.
Publicado: (2017)

Retinal Arteriolar Dilation Predicts Retinopathy in Adolescents With Type 1 Diabetes
por: Cheung, Ning, et al.
Publicado: (2008)

Peripheral sensory neuropathy is associated with altered postocclusive reactive hyperemia in the diabetic foot
por: Barwick, Alex L, et al.
Publicado: (2016)

Poorly controlled diabetes mellitus alters placental structure, efficiency, and plasticity
por: Nteeba, Jackson, et al.
Publicado: (2020)

Maternal Lipids as Strong Determinants of Fetal Environment and Growth in Pregnancies With Gestational Diabetes Mellitus
por: Schaefer-Graf, Ute M., et al.
Publicado: (2008)

Plasma heat shock protein response to euglycemia in type 2 diabetes
por: Atkin, Alexander S, et al.
Publicado: (2021)

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
por: Jaiswal, Mamta, et al.
Publicado: (2017)

Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes
por: Verhulst, Clementine E.M., et al.
Publicado: (2022)

Oxidation, Type 2 Diabetes, and Coronary Heart Disease: A Complex Interaction: Findings from a population-based study
por: Stranges, Saverio, et al.
Publicado: (2008)

Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Relationship of Urologic Complications With Health-Related Quality of Life and Perceived Value of Health in Men and Women With Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) Cohort
por: Jacobson, Alan M., et al.
Publicado: (2015)

Pregnancy Insulin, Glucose, and BMI Contribute to Birth Outcomes in Nondiabetic Mothers
por: Ong, Ken K., et al.
Publicado: (2008)

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
por: Wessells, Hunter, et al.
Publicado: (2018)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
por: Lopes-Virella, Maria F., et al.
Publicado: (2008)

Prevalence of peripheral neuropathy in pre-diabetes: a systematic review
por: Kirthi, Varo, et al.
Publicado: (2021)

Quantitative Assessment of Early Diabetic Retinopathy Using Fractal Analysis
por: Cheung, Ning, et al.
Publicado: (2009)

Clinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2009)

Circulating Levels of Adipocyte and Epidermal Fatty Acid–Binding Proteins in Relation to Nephropathy Staging and Macrovascular Complications in Type 2 Diabetic Patients
por: Yeung, Dennis C.Y., et al.
Publicado: (2009)

Impact of Early Diabetic Ketoacidosis on the Developing Brain
por: Aye, Tandy, et al.
Publicado: (2019)

Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case–control study
por: Taylor, Guy S, et al.
Publicado: (2020)

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
por: Bian, Xiaohui, et al.
Publicado: (2019)

Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts
por: DiCorpo, Daniel, et al.
Publicado: (2022)

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
por: Cousminer, Diana L., et al.
Publicado: (2018)

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
por: Tye, Sok Cin, et al.
Publicado: (2022)

Testosterone Concentration in Young Patients With Diabetes
por: Chandel, Anil, et al.
Publicado: (2008)

Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis
por: Götting, Christian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6c9chde5g8r2jmmjggbhfcufnb